日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Immune Checkpoint Inhibitor-Induced Pancreatic Injury (ICI-PI) in Adult Cancer Patients: A Systematic Review and Meta-Analysis

成人癌症患者免疫检查点抑制剂诱发的胰腺损伤（ICI-PI）：系统评价和荟萃分析

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17071080
Lee, Cha Len; Riya, Israt Jahan; Piya, Ifrat Jahan; Muniz, Thiago Pimentel; Butler, Marcus Otho; Saibil, Samuel David
免疫/内分泌
Checkpoint
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Female Oncofertility and Immune Checkpoint Blockade in Melanoma: Where Are We Today?

女性肿瘤生育力与黑色素瘤免疫检查点阻断：我们目前处于什么阶段？

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17020238
Lee, Cha Len; Martinez, Erika; Malon Gimenez, Diego; Muniz, Thiago Pimentel; Butler, Marcus Otho; Saibil, Samuel David
Checkpoint
发表日期：2025
文献求助 收藏

Circulating Oncometabolite 2-hydroxyglutarate as a Potential Biomarker for Isocitrate Dehydrogenase (IDH1/2) Mutant Cholangiocarcinoma

循环肿瘤代谢物2-羟基戊二酸作为异柠檬酸脱氢酶（IDH1/2）突变型胆管癌的潜在生物标志物

期刊:Molecular Cancer Therapeutics
影响因子:5.5
doi:10.1158/1535-7163.MCT-23-0460
Lee, Cha Len; O'Kane, Grainne M; Mason, Warren P; Zhang, Wen-Jiang; Spiliopoulou, Pavlina; Hansen, Aaron R; Grant, Robert C; Knox, Jennifer J; Stockley, Tracy L; Zadeh, Gelareh; Chen, Eric X
肿瘤
胆管癌
肿瘤免疫
代谢
发表日期：2024
文献求助 收藏

Synergistic Effects of the Combination of Alpelisib (PI3K Inhibitor) and Ribociclib (CDK4/6 Inhibitor) in Preclinical Colorectal Cancer Models

Alpelisib（PI3K抑制剂）和Ribociclib（CDK4/6抑制剂）联合用药在临床前结直肠癌模型中的协同作用

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms252413264
Aslam, Razia; Richards, Cathy E; Fay, Joanna; Hudson, Lance; Workman, Julie; Lee, Cha Len; Murphy, Adrian; O'Neill, Brian; Toomey, Sinead; Hennessy, Bryan T
CDK4
肿瘤
肠癌
肿瘤免疫
发表日期：2024
文献求助 收藏

Real-World Outcomes of Atezolizumab with Bevacizumab Treatment in Hepatocellular Carcinoma Patients: Effectiveness, Esophagogastroduodenoscopy Utilization and Bleeding Complications

阿特珠单抗联合贝伐珠单抗治疗肝细胞癌患者的真实世界结果：疗效、食管胃十二指肠镜检查利用率和出血并发症

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers16162878
Lee, Cha Len; Freeman, Mark; Burak, Kelly W; Moffat, Gordon T; O'Donnell, Conor D J; Ding, Philip Q; Lyubetska, Hanna; Meyers, Brandon M; Gordon, Vallerie; Kosyachkova, Ekaterina; Bucur, Roxana; Cheung, Winson Y; Knox, Jennifer J; Tam, Vincent C
肿瘤免疫
细胞生物学
肿瘤
发表日期：2024
文献求助 收藏

Preclinical evaluation of the CDK4/6 inhibitor palbociclib in combination with a PI3K or MEK inhibitor in colorectal cancer

CDK4/6抑制剂帕博西尼联合PI3K或MEK抑制剂治疗结直肠癌的临床前评估

期刊:Cancer Biology & Therapy
影响因子:4.6
doi:10.1080/15384047.2023.2223388
Lee, Cha Len; Cremona, Mattia; Farrelly, Angela; Workman, Julie A; Kennedy, Sean; Aslam, Razia; Carr, Aoife; Madden, Stephen; O'Neill, Brian; Hennessy, Bryan T; Toomey, Sinead
CDK4
肿瘤
肠癌
肿瘤免疫
发表日期：2023
文献求助 收藏

Germline BRCA2 variants in advanced pancreatic acinar cell carcinoma: A case report and review of literature

晚期胰腺腺泡细胞癌中生殖系BRCA2变异：病例报告及文献综述

期刊:World Journal of Gastroenterology
影响因子:5.4
doi:10.3748/wjg.v28.i45.6421
Lee, Cha Len; Holter, Spring; Borgida, Ayelet; Dodd, Anna; Ramotar, Stephanie; Grant, Robert; Wasson, Kristy; Elimova, Elena; Jang, Raymond W; Moore, Malcolm; Kim, Tae Kyoung; Khalili, Korosh; Moulton, Carol-Anne; Gallinger, Steven; O'Kane, Grainne M; Knox, Jennifer J
细胞生物学
肿瘤
BRCA2
肿瘤免疫
发表日期：2022
文献求助 收藏